Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Proximity search should include two or more words. Proximity operator ignored :~0
Page 1
Brincidofovir: A Novel Agent for the Treatment of Smallpox.
Ann Pharmacother. 2023 Oct;57(10):1198-1206. doi: 10.1177/10600280231151751. Epub 2023 Jan 23.
Ann Pharmacother. 2023.
PMID: 36688308
Review.
DATA SYNTHESIS: Two surrogate animal models were included in the Food and Drug Administration's (FDA) decision to approve brincidofovir: ectromelia virus in mice and rabbitpox in rabbits. Phases 2 and 3 studies established safety for approval. ...
DATA SYNTHESIS: Two surrogate animal models were included in the Food and Drug Administration's (FDA) decision to approve brincidofovir: …
Induction, treatment and prevention of eczema vaccinatum in atopic dermatitis mouse models.
Achdout H, Lustig S, Israely T, Erez N, Politi B, Tamir H, Israeli O, Waner T, Melamed S, Paran N.
Achdout H, et al.
Vaccine. 2017 Jul 24;35(33):4245-4254. doi: 10.1016/j.vaccine.2017.06.014. Epub 2017 Jun 20.
Vaccine. 2017.
PMID: 28625523
Unlike the severe manifestations of eczema vaccinatum in humans, current models present only mild symptoms that limits examination of potential therapeutics for eczema vaccinatum. The atopic dermatitis and eczema vaccinatum models we present here, are the first to simulate …
Unlike the severe manifestations of eczema vaccinatum in humans, current models present only mild symptoms that limits examination of potent …
Item in Clipboard
Cite
Cite